Financing the Response to HIV in Low- and Middle-Income Countries. Kates J, Wexler A and Lief E. (2015)

immage

As world leaders meet to discuss the future of financing for development and to endorse new Sustainable Development Goals (SDGs) in the post-MDG era, the global community is taking stock of the progress made as well as the work that remains to be done, including in addressing the HIV epidemic. Since the establishment of the MDGs in 2000, through 2013 new HIV infections have decreased by almost 40% and the number of AIDSrelated deaths has decreased by 35% since 2005. Still, in 2013, more than million people were newly infected with HIV and 1.5 million died. In addition, new infections are rising in some parts of the world and some groups continue to be at disproportionately high risk for HIV and lack access to needed treatment and other interventions. As a result, a new UNAIDS Lancet Commission Report on Defeating AIDS calls for a significant ramping up of funding for AIDS efforts now, stating that “the next 5 years present a window of opportunity to scale up the AIDS response to end AIDS as a public health problem by 2030”. While the Commission notes that affected countries with financial capacity should fund more of their AIDS response, the need for international funding, particularly from donor governments, remains high. UNAIDS and the Kaiser Family Foundation have been tracking donor government assistance provided to address HIV in low- and middle-income countries since 2002. This report provides data from 2014, the latest available on their funding.


Keywords: HIV, donors, governments, funding, data, Kaiser Family Foundation

Download Publication

HIV Prevention Research and Development Funding Trends, 2000–2014. AVAC, International AIDS Vaccine Initiative and UNAIDS. (2015)

immage

In its eleventh annual report, the HIV Vaccines & Microbicides Resource Tracking Working Group (the “Working Group”) documents biomedical HIV prevention research and development (R&D1) spending for the calendar year 2014, as well as reports on an analysis of investment trends spanning fourteen years. The Working Group generates estimates of R&D investment that can be compared year to year across options and strategies and funding sources, helping assess the impact of public policies aimed at accelerating scientific progress and to provide facts for advocacy. This effort provides transparency for funders, policy makers and HIV/AIDS advocates so they can better understand and track investment flows.

 


Keywords: HIV, prevention funding, investments, AIDS vaccines, PrEP

Download Publication

Unfinished Business: Tracking Global Commitments on AIDS, Volume 4. Hohlfelder E and Lluberes C. (2015)

immage

We have made incredible progress in the global fight against HIV/AIDS. But we are starting to see a dangerous level of complacency which threatens to reverse the real achievements made so far.

The world stands at a critical juncture: if we act with urgency in the next five years, we could end AIDS as an epidemic by 2030. But achieving this goal will require $12 billion annually more by 2020, targeted more effectively to reach the most vulnerable. Our new report calls on governments to prioritize support for the Global Fund; leaders in sub-Saharan Africa to invest more domestic resources in health; and the private sector to play a greater role.

 

Keywords: HIV, AIDS, ARV, treatment, spending, funding, donors 

 

Download publication

 

Download methodology

Scaling up HIV Treatment for MSM in Bangkok: What Does It Take? — A Modelling and Costing Study. Zhang L, Phanuphak N, Henderson K, et al. (2015)

immage

The HIV epidemic amongst men who have sex with men (MSM) in Bangkok is substantial. The population size of MSM in Bangkok is 120,000-250,000, with approximately one-third (33.5 percent) considered high-risk, characterized by their young age, multiple partnerships, frequent unprotected anal intercourse, and sexual activities around MSM hotspots. In metropolitan Bangkok, HIV prevalence among MSM reportedly increased from 21 percent to 28 percent between 2000 and 2012. The Thai Working Group of Estimation and Projection (2013) projected an estimate of 39,000 new HIV infections would occur in Thailand during 2012-2016, based on the AIDS Epidemic Model (AEM). 


Keywords: HIV, transmission, heterosexual, epidemic, infections, cost-effectiveness

Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Bhutan. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

Financing Global Health 2013: Transition in an Age of Austerity. Institute for Health Metrics and Evaluation. (2014)

immage

Financing Global Health 2013 is the fifth edition of this annually produced report on global health financing. As in previous years, this report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-s). Health financing is one of IHME’s core research areas, and the aim of the series is to provide much-needed information to global health stakeholders. Updated GHE and DAH estimates allow decision-makers to pinpoint funding gaps and investment opportunities vital to improving population health.

 

This year, IHME made a number of improvements to the data collection and methods implemented to produce Financing Global Health estimates. Both government health expenditure and development assistance for health estimates were updated and enhanced in 2013

Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Cambodia. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

Adding It Up 2014 - The Costs and Benefits of Investing in Sexual and Reproductive Health. UNFPA and Guttmacher Institute. (2014)

immage

The 2014 edition of Adding It Up expands the scope of the report and provides new estimates of the needs for and costs and benefits of sexual and reproductive health interventions in the following key areas: contraceptive services; maternal, newborn and other pregnancy-related care; selected services related to HIV prevention; and treating women for four other common STIs.


Keywords: STI, women, investments, children, deaths

Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Fiji. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

The Trans-Pacific Partnership Agreement: Implications for Access to Medicines and Public Health. Bhardwaj K and Oh C. (2014)

immage

The objective of this report is to provide an analysis of the provisions in the proposed TPPA in order to obtain a clearer understanding of their implications. It is hoped that the report will also be a useful resource for other stakeholders in the public health field.

The report analyses the key negotiating issues in the USA’s proposals (widely considered to be the basic negotiation text for the TPPA) which are likely to have an impact on access to medicines and public health.


Keywords: HIV, health, access, medicines, financing, 

Download Publication

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Monitoring_2018.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Mar
1
(1 Mar - 1 Mar)
Mar
3
Mar
8
(8 Mar - 8 Mar)